Nachrichten zur Boston Scientific Corp. Aktie

Boston Scientific succeeds in pivotal trial for leadless pacemaker

…

Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts

Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…

Top Analyst Reports for Boston Scientific, Arista Networks & Palo Alto Networks

Todays Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET)…

Investing in Cardiovascular MedTech Companies

Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from…

Boston Scientific pipeline strength fuels quarterly earnings beat By Investing.com

Boston Scientific pipeline strength fuels quarterly earnings beat…

Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised

Barring Neuromodulation, organic and operational revenues at Boston Scientifics (BSX) core business segments rise in the first quarter.…

Boston Scientific Q1 2024 Earnings Preview

…

Stryker auf "Tactical Outperform"-Liste gesetzt - Aktienanalyse

New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI: Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…

Whats in Store for Boston Scientific (BSX) in Q1 Earnings?

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan…

Aktie von Boston Scientific: Kurs mit wenig Bewegung (63,6701 €)

CODE Der jüngste Kurs betrug 68,40 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der…

Boston Scientific (BSX) Faces Rising Costs, Competition

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.…

Investing in Boston Scientific (NYSE:BSX) five years ago would have delivered you a 82% gain

Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...…

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

…

Boston Scientific merger with Axonics faces FTC scrutiny By Investing.com

Boston Scientific merger with Axonics faces FTC scrutiny…

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal

…

Boston Scientific EVP Wendy Carruthers sells $477,776 in stock By Investing.com

Boston Scientific EVP Wendy Carruthers sells $477,776 in stock…

Boston Scientific: The Markets Newest Mega-Cap Needs A Breather

…

Boston Scientific (BSX) and Scivita Medical Expand Partnership

Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.…

Scivita Medical broadens ties with Boston Scientific By Investing.com

Scivita Medical broadens ties with Boston Scientific…

Boston Scientific (BSX) Global Growth Robust, Macro Issues Ail

Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.…

Axonics ticks higher as Boston Scientific reiterates close in 1H24

…

Boston Scientific (BSX) Grows IC Business With New FDA Nod

The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.…

Boston Scientific completes €2 billion senior notes offering By Investing.com

Boston Scientific completes €2 billion senior notes offering…

Boston Scientific (BSX) Surges 4.6%: Will the Rally Continue?

Boston Scientific (BSX) is benefitting from an impressive gain in MedSurg market share and the strong adoption of WATCHMAN FLX.…

Boston Scientific (BSX) Completes First Case With Its PFA System

Boston Scientific (BSX) announces the completion of its first commercial cases with its FDA-cleared Farapulse PFA System in the United…

Heres Why You Should Invest in Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.…

Boston Scientifics (BSX) FARAPULSE PFA System Gets FDA Nod

Boston Scientific (BSX) secures FDA approval for the FARAPULSE PFA system.…

Boston Scientific’s stock jumps 3% after earnings beat and upbeat guidance

Medtech company’s earnings beat estimates in the latest quarter as sales rose 14.9%.…

Boston Scientific jumps as Q4 results exceed analyst expectations By Investing.com

Boston Scientific jumps as Q4 results exceed analyst expectations…

Boston Scientific (BSX) Q4 Earnings Top, Operating Margin Falls

Boston Scientific (BSX) sees an increase in organic and operational revenues in its core business segments and geographies in the…

The Zacks Analyst Blog Highlights Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific

Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific are included in this Analyst Blog.…

Boston Scientific: Portfolio Updates Driving Top-Line Growth

…

Palo Alto Networks, Nvidia, And 2 Other Stocks Insiders Are Selling , Boston Scientific (NYSE:BSX)

The Nasdaq 100 closed slightly lower on Tuesday. Investors, meanwhile, focused on some notable insider trades.…

Whats in Store for Boston Scientific (BSX) in Q4 Earnings?

Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the…

Boston Scientific: Continued M&A Drives More Growth

…

Why Axonics Stock Soared Today

The medical device maker agreed to be acquired by Boston Scientific.…

Axonic’s stock soars after cash buyout deal with Boston Scientific valued at $3.7 billion

…

Boston Scientific (BSX) Rides on Global Growth Amid Macro Woes

Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.…

Boston Scientific (BSX) Initiates AVANT GUARD Clinical Trial

Boston Scientifics (BSX) AVANT GUARD clinical trial is set to evaluate the FARAPULSE PFA System as the first-line treatment for…

Stocks making the biggest moves midday: Fisker, Lyft, Boston Scientific and more

These are the stocks posting the largest moves in midday trading.…

Baird names top medtech picks for 2024; bullish on Alcon, Axonics (NYSE:ALC)

sutthirat sutthisumdang Baird has chosen Alcon (NYSE:ALC), Stryker (NYSE:SYK), The Cooper Companies (NASDAQ:COO), Axonics (NASDAQ:AXNX) and Boston Scientific (NYSE:BSX) as…

Boston Scientific (BSX) Hits 52-Week High: Whats Aiding It?

Investors are optimistic about Boston Scientifics (BSX) impressive market share gain in the MedSurg segment.…

Electrodes For Medical Devices Market Size, Share & Trends Analysis Report 2023-2030, Featuring Company Profiles for 3M, Boston Scientific, GE Healthcare, Medtronic and X-trodes

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Electrodes For Medical Devices Market Size, Share & Trends Analysis…

Heres Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction…

Boston Scientific (BSX) Gains From Global Expansion, FX Woe Ails

Boston Scientifics (BSX) Endoscopy business within MedSurg benefits from strong worldwide demand for its broad range of GI and pulmonary…

Peripheral Vascular Guidewires Market Exclusive Research Report with Forecast to 2031

Companies covered in this study are Terumo Corp, Abbott Laboratories, Boston Scientific Corp, Asahi Intecc Co Ltd, Cardinal Health, Cook…

Boston Scientific (BSX) Closes the Relievant Medsystems Buyout

Boston Scientific (BSX) expands the neuromodulation portfolio with the acquisition of Relievant Medsystems.…

Heres Why You Should Retain Boston Scientific (BSX) Now

Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.…

Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue

…

: Boston Scientific posts better-than-expected Q3 earnings

Boston Scientific Corp. BSX posted better-than-expected third-quarter earnings early Thursday and raised its full-year guidance. The medical technology company had…